Day One Biopharma Expands to ADCs with $55M Drug Acquisition
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
- Latest
- Trending
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
Cryptocurrency trader Smileycapital predicts an altcoin uptrend by Q3, urges profit-taking for active traders, and long-term holding for passive investors.
Discover if the iShares Select Dividend ETF is the right Large Cap Value addition to your portfolio. Analyzing performance, costs, ...
Rosenblatt raises Nvidia price target to $200, citing new product lines & software enhancements as key drivers for future financial ...
Investors panic as Bitcoin dips below $65k; altcoins plunge. Discover expert insights on market moves, ETF outflows, and potential altseason.
Ethereum investors face $70M in liquidations amid market downturn and false reversal signals, showcasing impatience despite spot ETF anticipation.
Blackstone launches a $1.74B bid to take Infocom private; Teijin to sell its 58% stake, registering a 105B yen profit. ...
"Western companies bolster rare earths supply chain, reduce China's dominance, focus on vital materials for EVs, wind turbines, and drones."
"UK business investment has lagged behind G7 peers for decades, according to IPPR, impacting economic growth and productivity."
"ETH drops below $3,500 amid a 30% rise in trading volume, as investors await SEC's decision on spot Ether ETFs, ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.